Celularity (CELU) Gains from Investment Securities (2020 - 2025)
Historic Gains from Investment Securities for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to $4.3 million.
- Celularity's Gains from Investment Securities rose 69719.89% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 29584.78%. This contributed to the annual value of $434000.0 for FY2024, which is 10041.6% up from last year.
- According to the latest figures from Q3 2025, Celularity's Gains from Investment Securities is $4.3 million, which was up 69719.89% from $1.3 million recorded in Q2 2025.
- In the past 5 years, Celularity's Gains from Investment Securities ranged from a high of $36.5 million in Q1 2021 and a low of -$52.8 million during Q4 2022
- In the last 5 years, Celularity's Gains from Investment Securities had a median value of -$718000.0 in 2024 and averaged -$7.1 million.
- Within the past 5 years, the most significant YoY rise in Celularity's Gains from Investment Securities was 839170.72% (2021), while the steepest drop was 6656418.59% (2021).
- Quarter analysis of 5 years shows Celularity's Gains from Investment Securities stood at -$23.3 million in 2021, then crashed by 126.76% to -$52.8 million in 2022, then skyrocketed by 90.18% to -$5.2 million in 2023, then surged by 86.08% to -$722000.0 in 2024, then soared by 690.58% to $4.3 million in 2025.
- Its Gains from Investment Securities was $4.3 million in Q3 2025, compared to $1.3 million in Q2 2025 and -$242000.0 in Q1 2025.